BRIEF published on 05/27/2025 at 16:11, 11 months 12 days ago Les actionnaires de Medios AG approuvent les résolutions lors de l'assemblée générale annuelle de 2025 Stratégie De Croissance Medios AG Assemblée Générale Annuelle Plan D'options D'achat D'actions Résolutions Des Actionnaires
BRIEF published on 05/27/2025 at 16:11, 11 months 12 days ago Medios AG Shareholders Approve Resolutions at 2025 AGM Growth Strategy Annual General Meeting Stock Option Plan Medios AG Shareholder Resolutions
PRESS RELEASE published on 05/27/2025 at 16:06, 11 months 12 days ago Medios AG Annual General Meeting 2025: Shareholders approve all proposed resolutions Medios AG shareholders approve all proposed resolutions at the 2025 Annual General Meeting. CEO highlights growth strategy and profitability improvements Growth Strategy Shareholders Profitability Medios AG Resolutions
BRIEF published on 05/13/2025 at 07:55, 11 months 26 days ago Medios AG annonce un bon début d'exercice 2025 Résultats Financiers Stratégie De Croissance Medios AG Prévisions Pour 2025 Pharmaceutique Spécialisée
BRIEF published on 05/13/2025 at 07:55, 11 months 26 days ago Medios AG Reports Strong Start to 2025 Financial Year Growth Strategy Financial Results Medios AG Specialty Pharma 2025 Forecast
PRESS RELEASE published on 05/13/2025 at 07:50, 11 months 26 days ago Medios starts 2025 financial year successfully with significant increase in earnings Medios AG reports successful start to 2025 financial year with revenue up 6.2% to €484.7 million and significant increase in earnings. Earnings per share rose to €0.25 Revenue Increase Financial Year Medios AG Earnings Growth Specialty Pharma
BRIEF published on 05/12/2025 at 19:03, 11 months 27 days ago Medios AG Ushers in New Phase of Development with Leadership Changes Leadership Transition Medios AG CEO Change Corporate Development Specialty Pharma
BRIEF published on 05/12/2025 at 19:03, 11 months 27 days ago Medios AG entre dans une nouvelle phase de développement avec des changements de direction Medios AG Développement De L'entreprise Changement De PDG Transition De Leadership Pharmaceutique Spécialisée
BRIEF published on 05/12/2025 at 19:01, 11 months 27 days ago Leadership Changes at Medios AG Executive Board Leadership Transition Medios AG CEO Departure Pharma Industry
BRIEF published on 05/12/2025 at 19:01, 11 months 27 days ago Changements de direction chez Medios AG Medios AG Conseil Exécutif Transition De Leadership Industrie Pharmaceutique Départ Du PDG
Published on 05/09/2026 at 01:30, 4 hours 7 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 5 hours 37 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 8 hours 58 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 10 hours 24 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 10 hours 34 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 10 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 10 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 10 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 10 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 10 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
